Metachronous Bladder Tumors In Patients Managed Endoscopically For Primary Upper Tract TCC: Are They Predictive Of Primary Upper Track Recurrence?

Main Category: Urology / Nephrology
Also Included In: Cancer / Oncology
Article Date: 08 Jun 2008 - 0:00 PDT

email to a friend   printer friendly   view / write opinions   rate article

ORLANDO, FL (UroToday.com) - The authors report a retrospective analysis of a 53-patient cohort who underwent systematic urothelial surveillance for at least 24 months following initial endoscopic laser treatment of upper tract TCC.

The authors report that nearly all (97%) bladder tumors that were found in this patient population during surveillance were low grade and superficial. This data is clearly a testament to astute patient selection that was used to guide patients toward endoscopic treatment of upper tract disease. The authors were clearly able to discern non-hostile urothelial disease biology when advising against nephroureterectomy.

I am willing to bet that not many of these patients had sessile upper tract lesions at the onset (Read a Related Review).

Presented by Raymond W Pak, MD, James Kelly, MD, Brent Yanke, MD, Scott Hubosky, MD, and Demetrius Bagley, MD, at the Annual Meeting of the American Urological Association (AUA) - May 17 - 22, 2008. Orange County Convention Center - Orlando, Florida, USA.

Reported by UroToday.com Contributing Editor Alexander Kutikov, MD

UroToday - the only urology website with original content written by global urology key opinion leaders actively engaged in clinical practice.

To access the latest urology news releases from UroToday, go to: www.urotoday.com

Copyright © 2008 - UroToday